Internal Medicine, Hematology · Hershey, PA
NPI
1558522565
Since 2008
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
500 University Dr
Hershey, PA, 17033
Phone (717) 531-8401
Groups this clinician bills Medicare through
Medicare paid, 2024
$30K
477 services
Medicare patients, 2024
208
Average age 71
Drug cost, 2024
$4.7M
970 prescriptions
Company payments, 2025
$472
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Natthapol Songdej was code 99214 (office e&m - established), 175 times for 80 patients. In total Natthapol Songdej billed 477 services in 18 codes, and Medicare paid $30K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 175 | 80 | $70.00 | $12K |
| 99213 Office E&M - Established | Facility | 112 | 77 | $41.31 | $4,626 |
| 99232 Hospital E&M - Subsequent | Facility | 48 | 18 | $59.95 | $2,878 |
| 99222 Hospital E&M - Initial | Facility | 33 | 32 | $99.16 | $3,272 |
| 99215 Office E&M - Established | Facility | 23 | 13 | $100.30 | $2,307 |
| 99204 Office E&M - New | Facility | 13 | 13 | $93.45 | $1,215 |
By year: 2022 $31K for 448 services; 2023 $30K for 443 services; 2024 $30K for 477 services.
Medicare prescription drug claims, 2024
In 2024, the drug Natthapol Songdej prescribed most often to Medicare patients was Eliquis (Apixaban), with 100 prescriptions and refills. In total Natthapol Songdej wrote 970 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 100 | 169 | 21 | $96K |
| Calquence Acalabrutinib Maleate | 50 | 50 | Under 11 | $693K |
| Xarelto Rivaroxaban | 49 | 107 | 11 | $56K |
| Hydroxyurea Generic | 49 | 89 | 12 | $937 |
| Acyclovir Generic | 30 | 80 | 13 | $831 |
| Pomalyst Pomalidomide | 28 | 28 | Under 11 | $648K |
| Brukinsa Zanubrutinib | 27 | 27 | Under 11 | $376K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 35 | Under 11 | $120 |
| Imatinib Mesylate Generic | 24 | 24 | Under 11 | $21K |
| Ninlaro Ixazomib Citrate | 22 | 22 | Under 11 | $252K |
| Revlimid Lenalidomide | 22 | 22 | Under 11 | $385K |
| Enoxaparin Sodium Generic | 21 | 27 | Under 11 | $5,872 |
| Valacyclovir Valacyclovir Hcl | 21 | 37 | Under 11 | $751 |
| Atovaquone Generic | 20 | 20 | Under 11 | $8,378 |
| Celecoxib Generic | 20 | 22 | Under 11 | $292 |
Brand drugs: - claims; generic drugs: 543 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Natthapol Songdej $472 ($472 in general payments such as food, travel and fees) from 3 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $300.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.